These results, together with a former report displaying that a small-molecule ACKR3 agonist CCX771 exhibits anxiolytic-like conduct in mice,two assistance the strategy of focusing on ACKR3 as a singular strategy to modulate the opioid process, which could open new therapeutic avenues for opioid-